药物/ADA复合物的生物分布:免疫复合物形成对抗体分布的影响
Eugenia Opolka-Hoffmann1, Martin R Edelmann2,3, Michael B Otteneder4
1Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, DE-82377, Penzberg, Germany. Eugenia.opolka-hoffmann@roche.com.
了解免疫性对于治疗性蛋白质至关重要. 免疫复合体的形成显著加速药物清除,改变生物分布,影响药物的疗效和安全.
科学领域:
- 药理动力学和药物新陈代谢
- 免疫学和生物化学
背景情况:
- 治疗性单克隆抗体 (mAbs) 被广泛使用,但其疗效可能会受到免疫性影响.
- 抗药抗体 (ADA) 与mAbs形成免疫复合体 (IC),导致疗效降低或清除加速.
研究的目的:
- 调查药物/ADA免疫复合体 (IC) 的体内生物分布和药理动力学影响.
- 了解免疫性对治疗性蛋白质生物行为的影响.
主要方法:
- 一种类似于药物的IgG被放射性标记了三.
- 免疫复合体 (ICs) 通过使用多克隆的ADA对抗药物-IgG而形成.
- 活体生物分布研究在动物中进行,使用 autoradiography 和直接放射性测量.
主要成果:
- 放射性标记IC剂量的65%在24小时内排出,而非复杂药物的6%.
- 自主放射显示了早期的IC沉积在肝脏,肺和脏.
- 研究表明,ICs被网膜内皮系统吸收,降解,代谢物通过脏分泌或再利用.
结论:
- 免疫复合体的形成显著改变了治疗性蛋白质的生物分布和清除.
- 了解免疫性对于预测和管理生物药物的体内行为至关重要.
- 这些发现强调了评估药物开发中的IC形成的重要性.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
相关概念视频
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Drug Distribution: Plasma Protein Binding
Drug Distribution: Tissue Binding
For...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
